Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

Gastroparesis Drugs Market Research Report 2021: Global Industry Overview, Size, Share, Trends, Growth and Forecast Till 2026

Global Banking And Finance 1 News

According to IMARC Group’s latest report, titled Gastroparesis Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026; the global gastroparesis drugs market reached a value of US$ XX Billion in 2020. Gastroparesis or stomach paralysis represents a medical condition that affects the normal and spontaneous muscle movement in the stomach. It disrupts the digestion process and causes nausea, abdominal pain, vomiting, problems with maintaining blood sugar levels and nutrition absorption, etc. Presently, gastroparesis is treated under the guidance of doctors using several drugs, such as domperidone, metoclopramide, erythromycin, diphenhydramine, ondansetron, prochlorperazine, etc.

AVvXsEh2p9tTW 8ObFP DDvfuECtjSCM oJIWS99WPMYEKWU zNG N mG1muffZ8Iq85sKAVFX pBLgB5jvltyxJ15NxM2jnW3rkyhYNnqMl5A4HO4iH1 2i5P0KbdHnVu5U8KhrEMoEeNeUaiulPf - Global Banking | Finance

Request for a PDF sample of this report:


We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.’

The elevating levels of urbanization, the sedentary lifestyles of consumers, and the growing number of individuals who drink or smoke are leading to the rising prevalence of diabetes across the globe. This, along with the expanding geriatric population, who are relatively more susceptible to developing stomach paralysis, is primarily driving the gastroparesis drugs market. Moreover, these drugs help enhance gastrointestinal motility by improving the frequency of contraction. Owing to this, they are being increasingly utilized for treating idiopathic gastroparesis, which is further catalyzing the market growth. Additionally, the increasing number of individuals suffering from gastroparesis after the vague nerve and its branches are damaged during surgical operations is also propelling the product demand. Apart from this, the improving healthcare infrastructures and the inflating demand for user-friendly drugs are augmenting the global market. Furthermore, various leading manufacturers are developing numerous advanced and effective drugs that can be administered via the nasal cavity of individuals. This, in turn, is projected to stimulate the gastroparesis drugs market over the forecasted period. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026.


As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.


Competitive Landscape:

·         Abbott Laboratories

·         Abbvie Inc

·         AstraZeneca Plc

·         Bausch Health Companies Inc

·         Becton Dickinson and Company

·         Boston Scientific Corporation

·         Evoke Pharma

·         Medtronic plc

·         Neurogastrx Inc.

·         Sanofi S.A

·         Takeda Pharmaceutical Company Limited

·         Theravance Biopharma

Key Market Segmentation:

Breakup by Disease Type:

·      Diabetic Gastroparesis

·      Idiopathic Gastroparesis

·      Post-surgical Gastroparesis

·      Others

Breakup by Drug Class:

·      Prokinetic Agents

·      Antiemetic Agents

·      Botulinum Toxin Injections

Breakup by Distribution Channel:

·      Hospitals and Clinics

·      Pharmacies

·      Online Stores

Breakup by Region:

·      North America (United States, Canada)

·      Europe (Germany, France, United Kingdom, Italy, Spain, Others)

·      Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)

·      Latin America (Brazil, Mexico, Others)

·      Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)


Ask Analyst for Customization and Explore full report with TOC & List of Figures


We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

Key highlights of the report:                                                     

  • Market Performance (2015-2020)
  • Market Outlook (2021-2026)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group:

Cosmetic Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026


Europe Aluminum Powder Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026


Smart Mirror Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026


GCC Oral Hygiene Market : Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026


Europe PVC Pipes Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026



About Us                                                                   

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact US:


30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [email protected]

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800


Global Banking & Finance Review


Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post